Metabolic Syndrome and Related Disorders
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.6 | Q4 | 25.1% | 0.548 | Q2 | 64.4% |
| 2024 | 1.7 | Q3 | 28.2% | 0.520 | Q3 | 63.5% |
| 2023 | 1.3 | Q4 | 26.5% | 0.552 | Q2 | 68.1% |
| 2022 | 2.1 | Q4 | 33.1% | 0.613 | Q2 | 72.7% |
| 2021 | 2.4 | Q4 | 45.3% | 0.611 | Q2 | 73.4% |
| 2020 | — | — | 0.598 | Q3 | 71.7% | |
| 2019 | — | — | 0.602 | Q2 | 72.7% | |
| 2018 | — | — | 0.726 | Q2 | 76.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1557-8518
ISSN
1540-4196
region
Northern America
coverage
2003-2026